Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419049 · ClinicalTrials.gov registry record · NA
Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design
A NA study of Spina Bifida, sponsored by University of St. Augustine for Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06419049: Recruiting NA study of Spina Bifida, sponsored by University of St. Augustine for Health Sciences.
NCT06419049 is a NA study of Spina Bifida that is actively recruiting participants, run by University of St. Augustine for Health Sciences. The registered enrollment target is 12 participants, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06419049, a NA study of Spina Bifida, is actively recruiting participants, sponsored by University of St. Augustine for Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this single-subject study is to investigate children with spinal bifida who have significant knee limitations in lower extremity passive range of motion to answer the following research questions: 1. Is a home standing program effective in reducing lower extremity passive range of motion limitations in children with Spina Bifida? 2. Does a home standing program change the quality of functional movement in children with spina bifida? 3. Does a home standing program change a child's performance in daily activities, mobility, and social/cognitive domains? 4. Does a home standing program change a child's health-related quality of life in children with spinal bifida? 5. Does a home standing program result in a change in gait velocity in children with Spina Bifida?
Conditions Studied
Interventions
- DEVICE Altimate Medical EasyStand Bantam
Study Locations (1)
California
- University of St. Augustine - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-02-23 |
| Est. Completion | 2025-08 |
| Phase | NA |
What NCT06419049 shows while recruiting
NCT06419049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Altimate Medical EasyStand Bantam is the first listed.
NCT06419049 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06419049 about?
NCT06419049 is a clinical study titled "Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design". The purpose of this single-subject study is to investigate children with spinal bifida who have significant knee limitations in lower extremity passive range of motion to answer the following research questions: 1. Is a home standing program effective in reducing lower extremity passive range of mo...
What is the current status of trial NCT06419049?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-02-23. Estimated completion is 2025-08.
What conditions does trial NCT06419049 study?
This clinical trial studies the following conditions: Spina Bifida.
What interventions are being tested in trial NCT06419049?
The interventions under investigation include: Altimate Medical EasyStand Bantam (DEVICE).
Who is sponsoring clinical trial NCT06419049?
This trial is sponsored by University of St. Augustine for Health Sciences, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06419049 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06419049's enrollment target sits among peer trials
12 13th of 16 higher than 2 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI